AAAAAA
Results: 1-25/51
Authors:
Panoskaltsis-Mortari, A
Hermanson, JR
Haddad, IY
Wangensteen, OD
Blazar, BR
Citation: A. Panoskaltsis-mortari et al., Intercellular adhesion molecule-1 (ICAM-1, CD54) deficiency segregates theunique pathophysiological requirements for generating idiopathic pneumoniasyndrome (IPS) versus graft-versus-host disease following allogeneic murine bone marrow transplantation, BIOL BLOOD, 7(7), 2001, pp. 368-377
Authors:
Arora, M
Wagner, JE
Davies, SM
Blazar, BR
Defor, T
Enright, H
Miller, WF
Weisdorf, DJ
Citation: M. Arora et al., Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease, BIOL BLOOD, 7(5), 2001, pp. 265-273
Authors:
Blazar, BR
McKenna, HJ
Panoskaltsis-Mortari, A
Taylor, PA
Citation: Br. Blazar et al., Flt3 ligand (FL) treatment of murine donors does not modify graft-versus host disease (GVHD) but FL treatment of recipients post-bone marrow transplantation accelerates GVHD lethality, BIOL BLOOD, 7(4), 2001, pp. 197-207
Authors:
Hixon, JA
Blazar, BR
Anver, MR
Wiltrout, RH
Murphy, WJ
Citation: Ja. Hixon et al., Antibodies to CD40 induce a lethal cytokine cascade after syngeneic bone marrow transplantation, BIOL BLOOD, 7(3), 2001, pp. 136-143
Authors:
Bracho, F
Krailo, MD
Shen, V
Bergeron, S
Davenport, V
Liu-Mares, W
Blazar, BR
Panoskaltsis-Mortari, A
van de Ven, C
Secola, R
Ames, MM
Reid, JM
Reaman, GH
Cairo, MS
Citation: F. Bracho et al., A phase I clinical, pharmacological, and biological trial of interleukin 6plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: Enhanced hematological responses but a high incidence of grade III/IV constitutionaltoxicities, CLIN CANC R, 7(1), 2001, pp. 58-67
Authors:
Cairo, MS
Shen, V
Krailo, MD
Bauer, M
Miser, JS
Sato, JK
Blatt, J
Blazar, BR
Frierdich, S
Liu-Mares, W
Reaman, GH
Citation: Ms. Cairo et al., Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children withrecurrent or refractory solid tumors: A Children's Cancer Group report, J PED H ONC, 23(1), 2001, pp. 30-38
Authors:
Yang, SX
Milla, C
Panoskaltsis-Mortari, A
Ingbar, DH
Blazar, BR
Haddad, IY
Citation: Sx. Yang et al., Human surfactant protein A suppresses T cell-dependent inflammation and attenuates the manifestations of idiopathic pneumonia syndrome in mice, AM J RESP C, 24(5), 2001, pp. 527-536
Authors:
Yang, SX
Porter, VA
Cornfield, DN
Milla, C
Panoskaltsis-Mortari, A
Blazar, BR
Haddad, IY
Citation: Sx. Yang et al., Effects of oxidant stress on inflammation and survival of iNOS knockout mice after marrow transplantation, AM J P-LUNG, 281(4), 2001, pp. L922-L930
Authors:
Welniak, LA
Blazar, BR
Wiltrout, RH
Anver, MR
Murphy, WJ
Citation: La. Welniak et al., Role of interleukin-12 in acute graft-versus-host disease, TRANSPLAN P, 33(1-2), 2001, pp. 1752-1753
Authors:
Ziegler, TR
Panoskaltsus-Mortari, A
Gu, LH
Jonas, CR
Farrell, CL
Lacey, DL
Jones, DP
Blazar, BR
Citation: Tr. Ziegler et al., Regulation of glutathione redox status in lung and liver by conditioning regimens and keratinocyte growth factor in murine allogeneic bone marrow transplantation, TRANSPLANT, 72(8), 2001, pp. 1354-1362
Authors:
Krishnamurti, L
Blazar, BR
Wagner, JE
Citation: L. Krishnamurti et al., Bone marrow transplantation without myeloablation for sickle cell disease., N ENG J MED, 344(1), 2001, pp. 68-68
Authors:
Prlic, M
Blazar, BR
Khoruts, A
Zell, T
Jameson, SC
Citation: M. Prlic et al., Homeostatic expansion occurs independently costimulatory signals, J IMMUNOL, 167(10), 2001, pp. 5664-5668
Authors:
Welniak, LA
Khaled, AR
Anver, MR
Komschlies, KL
Wiltrout, RH
Durum, S
Ruscetti, FR
Blazar, BR
Murphy, WJ
Citation: La. Welniak et al., Gastrointestinal cells of IL-7 receptor null mice exhibit increased sensitivity to irradiation, J IMMUNOL, 166(5), 2001, pp. 2923-2928
Authors:
Blazar, BR
Kwon, BS
Panoskaltsis-Mortari, A
Kwak, KB
Peschon, JJ
Taylor, PA
Citation: Br. Blazar et al., Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients, J IMMUNOL, 166(5), 2001, pp. 3174-3183
Authors:
Blazar, BR
Lindberg, FP
Ingulli, E
Panoskaltsis-Mortari, A
Oldenborg, PA
Iizuka, K
Yokoyama, WM
Taylor, PA
Citation: Br. Blazar et al., CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells, J EXP MED, 194(4), 2001, pp. 541-549
Authors:
Taylor, PA
Noelle, RJ
Blazar, BR
Citation: Pa. Taylor et al., CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade, J EXP MED, 193(11), 2001, pp. 1311-1317
Authors:
Deeg, HJ
Blazar, BR
Bolwell, BJ
Long, GD
Schuening, F
Cunningham, J
Rifkin, RM
Abhyankar, S
Briggs, AD
Burt, R
Lipani, J
Roskos, LK
White, JM
Havrilla, N
Schwab, G
Heslop, HE
Citation: Hj. Deeg et al., Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL, BLOOD, 98(7), 2001, pp. 2052-2058
Authors:
Blazar, BR
Krieg, AM
Taylor, PA
Citation: Br. Blazar et al., Synthetic unmethylated cytosine-phosphate-guanosine oligodeoxynucleotides are potent stimulators of antileukemia responses in naive and bone marrow transplant recipients, BLOOD, 98(4), 2001, pp. 1217-1225
Authors:
Taylor, PA
Lees, CJ
Waldmann, H
Noelle, RJ
Blazar, BR
Citation: Pa. Taylor et al., Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions, BLOOD, 98(2), 2001, pp. 467-474
Authors:
Weinberg, K
Blazar, BR
Wagner, JE
Agura, E
Hill, BJ
Smogorzewska, M
Koup, RA
Betts, MR
Collins, RH
Douek, DC
Citation: K. Weinberg et al., Factors affecting thymic function after allogeneic hematopoietic stem celltransplantation, BLOOD, 97(5), 2001, pp. 1458-1466
Authors:
Pawlowska, AB
Hashino, S
McKenna, H
Weigel, BJ
Taylor, PA
Blazar, BR
Citation: Ab. Pawlowska et al., In vitro tumor-pulsed or in vivo Flt3 ligand-generated dendritic cells provide protection against acute myelogenous leukemia in nontransplanted or syngeneic bone marrow-transplanted mice, BLOOD, 97(5), 2001, pp. 1474-1482
Authors:
Boussiotis, VA
Chen, ZM
Zeller, JC
Murphy, WJ
Berezovskaya, A
Narula, S
Roncarolo, MG
Blazar, BR
Citation: Va. Boussiotis et al., Altered T-cell receptor+CD28-mediated signaling and blocked cell cycle progression in interleukin 10 and transforming growth factor-beta-treated alloreactive T cells that do not induce graft-versus-host disease, BLOOD, 97(2), 2001, pp. 565-571
Authors:
Koh, CY
Blazar, BR
George, T
Welniak, LA
Capitini, CM
Raziuddin, A
Murphy, WJ
Bennett, M
Citation: Cy. Koh et al., Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo, BLOOD, 97(10), 2001, pp. 3132-3137
Authors:
Welniak, LA
Blazar, BR
Anver, MR
Wiltrout, RH
Murphy, WJ
Citation: La. Welniak et al., Opposing roles of interferon-gamma on CD4(+) T cell-mediated graft-versus-host disease: Effects of conditioning, BIOL BLOOD, 6(6), 2000, pp. 604-612
Authors:
Cragg, L
Blazar, BR
Defor, T
Kolatker, N
Miller, W
Kersey, J
Ramsay, N
McGlave, P
Filipovich, A
Weisdorf, D
Citation: L. Cragg et al., A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease, BIOL BLOOD, 6(4A), 2000, pp. 441-447